Leonard S. Schleifer - Apr 5, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Stock symbol
REGN
Transactions as of
Apr 5, 2022
Transactions value $
-$5,051,269
Form type
4
Date filed
4/7/2022, 04:04 PM
Previous filing
Apr 4, 2022
Next filing
May 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$3.17M -4.46K -24.39% $710.05 13.8K Apr 5, 2022 By Trust F1, F2
transaction REGN Common Stock Sale -$1.88M -2.65K -19.18% $710.04 11.2K Apr 6, 2022 By Trust F1, F3
holding REGN Common Stock 466K Apr 5, 2022 Direct
holding REGN Common Stock 200K Apr 5, 2022 2021 GRAT
holding REGN Common Stock 5.87K Apr 5, 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 4,461 shares of Company stock on April 5, 2022 at prices ranging from $710.00 to $710.22. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 5, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 2,653 shares of Company stock on April 6, 2022 at prices ranging from $710.00 to $710.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 6, 2022 at each separate price.